This webinar is brought to you by Equifund Technologies, LLC.
On this edition of our “Interview with Management” webinar series, we sit down with Mivium’s CEO Eric Tsai.
Topics we discuss include:
For more information on Mivium and how you can invest, please visit the company’s offering page here: https://invest.equifund.com/offering/mivium/details
Over the weekend, we talked about how the current banking crisis could impact the commercial real estate (CRE) sector in the next 12-24 months. But as
For decades, retail investors have traditionally been the final exit strategy for institutions. But maybe not for long…
Why the customer-shareholder flywheel could be the one thing to look for…
What to do when things get a little crazy…
By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.
Proprietary devices that could revolutionize spinal surgery and greatly improve success rates, reduce pain, and lower costs.
Over 20 patents have been issued to protect the company's technologies.
Just received FDA clearance for their next-generation KG2 spinal fusion technology.
The next 8 slides will allow us to process your investment. Note that these next steps are a legal requirement – Thank you for your patience and financial support of this investment opportunity. Jordan Gillissie – CEO
Before we execute the investment, it’s important for us to make sure you’re comfortable and knowledgeable in early stage investing. We want to make sure that you:
We are currently upgrading our system. If you click submit and the process does not continue in a few seconds, please refresh this page manually, and click Invest Now again and you should be moved on to the next step.
Please wait a few minutes while we create your account. An email will be sent to you shortly to confirm your admittance. Should the email be delivered to your spam or promotions folder, we recommend you move it to your inbox and mark Equifund as a safe sender.
If you have not received the email in 5 minutes, please click here to have it resent.
Questions? Our customer service team is always here to help – 1-866-338-3004
